Newamsterdam Pharma Co N.v.
NAMS
Revenue
2.28M
▲878.00k▲62.67%
3 Months ChangeAssets
471.10M
▼-60.49M▼-11.38%
6 Months ChangeLiabilities
59.25M
▼-17.41M▼-22.71%
3 Months ChangeFree Cash Flow
-54.99M
▼-23.12M▼-72.54%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001193125-24-239687
2024-08-09
Form 8-K
ID: 0001193125-24-197971
2024-08-07
Form 10-Q
ID: 0000950170-24-092281
2024-08-07
Form 8-K
ID: 0000950170-24-092279
2024-07-29
Form 8-K
ID: 0001193125-24-186747
2024-07-18
Form 8-K
ID: 0001193125-24-180754
2024-06-11
Form 8-K
ID: 0001193125-24-158751
2024-06-07
Form 8-K
ID: 0001193125-24-157374
2024-05-09
Form 8-K
ID: 0000950170-24-056292
2024-05-08
Form 10-Q
ID: 0000950170-24-055767